• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期使用阿片类拮抗剂治疗对阿片类和非阿片类药物反应的改变。

Modification of the response to opioid and nonopioid drugs by chronic opioid antagonist treatment.

作者信息

Yoburn B C, Inturrisi C E

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy & Allied Health Professions, St. John's University, Jamaica, NY 11439.

出版信息

Life Sci. 1988;42(18):1689-96. doi: 10.1016/0024-3205(88)90034-3.

DOI:10.1016/0024-3205(88)90034-3
PMID:3362035
Abstract

Chronic exposure to opioid antagonists increases the analgesic actions of opioids such as morphine. In the present studies, morphine's analgesic potency was increased (supersensitivity) following an 8 day subcutaneous naltrexone implant in mice, but not following a 1 day implant. Supersensitivity was maximal 24hr following the 8 day implant and declined linearly and had returned to control levels by 120hr. Implantation of naltrexone pellets for 8 days was found to increase the relative analgesic potency of methadone by 120%, while the lethal potency of cocaine was slightly (19%), but significantly, decreased. In contrast, identical treatment did not alter the potency of the benzodiazepine alprazolam to induce ataxia.

摘要

长期接触阿片类拮抗剂会增强吗啡等阿片类药物的镇痛作用。在本研究中,小鼠皮下植入纳曲酮8天后,吗啡的镇痛效力增强(超敏反应),但植入1天则无此现象。超敏反应在8天植入后24小时达到最大值,然后呈线性下降,至120小时时恢复到对照水平。发现植入纳曲酮丸8天可使美沙酮的相对镇痛效力提高120%,而可卡因的致死效力略有降低(19%),但具有显著性。相比之下,相同处理并未改变苯二氮䓬类药物阿普唑仑诱导共济失调的效力。

相似文献

1
Modification of the response to opioid and nonopioid drugs by chronic opioid antagonist treatment.长期使用阿片类拮抗剂治疗对阿片类和非阿片类药物反应的改变。
Life Sci. 1988;42(18):1689-96. doi: 10.1016/0024-3205(88)90034-3.
2
Chronic opioid antagonist treatment: assessment of receptor upregulation.
Eur J Pharmacol. 1989 Nov 7;170(3):193-200. doi: 10.1016/0014-2999(89)90539-6.
3
Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment.慢性纳曲酮治疗后大鼠吗啡镇痛效力增强及脑内阿片类结合位点增加。
Life Sci. 1985 Jun 17;36(24):2325-32. doi: 10.1016/0024-3205(85)90322-4.
4
Increased analgesic potency of mu agonists after continuous naloxone infusion in rats.持续输注纳洛酮后大鼠体内μ阿片受体激动剂镇痛效能增强。
J Pharmacol Exp Ther. 1991 Nov;259(2):582-9.
5
Chronic opioid antagonist treatment facilitates nonopioid, stress-induced analgesia.
Pharmacol Biochem Behav. 1987 Jul;27(3):525-7. doi: 10.1016/0091-3057(87)90359-5.
6
Mu-opioid receptor up-regulation and functional supersensitivity are independent of antagonist efficacy.μ-阿片受体上调和功能超敏性与拮抗剂效能无关。
J Pharmacol Exp Ther. 2007 Nov;323(2):701-7. doi: 10.1124/jpet.107.127019. Epub 2007 Aug 14.
7
Different opioid systems may participate in post-electro-convulsive shock (ECS) analgesia and catalepsy.不同的阿片系统可能参与电惊厥休克(ECS)后的镇痛和僵住症。
Brain Res. 1981 Aug 31;219(2):385-96. doi: 10.1016/0006-8993(81)90301-2.
8
Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.超低剂量的纳曲酮或埃托啡可增强吗啡在小鼠中的镇痛效力,并减轻耐受性/依赖性。
Brain Res. 1997 May 23;757(2):176-90. doi: 10.1016/s0006-8993(97)00197-2.
9
Potentiation of opioid analgesia by the antidepressant nefazodone.抗抑郁药奈法唑酮增强阿片类镇痛作用。
Eur J Pharmacol. 1992 Feb 18;211(3):375-81. doi: 10.1016/0014-2999(92)90395-k.
10
Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse.小鼠体内的药效学超敏反应与阿片受体上调
J Pharmacol Exp Ther. 1986 Oct;239(1):132-5.

引用本文的文献

1
Naltrexone Maintenance: Effect on Morphine Sensitivity in Normal Volunteers.纳曲酮维持治疗:对正常志愿者吗啡敏感性的影响。
Am J Addict. 1993;2(1):34-38.
2
Naltrexone extended-release injection: an option for the management of opioid abuse.纳曲酮长效注射剂:一种用于管理阿片类药物滥用的选择。
Subst Abuse Rehabil. 2011 Dec 6;2:219-26. doi: 10.2147/SAR.S17920. eCollection 2011.
3
Stabilization of the μ-opioid receptor by truncated single transmembrane splice variants through a chaperone-like action.截断的单跨膜剪接变异体通过伴侣样作用稳定 μ 阿片受体。
J Biol Chem. 2013 Jul 19;288(29):21211-21227. doi: 10.1074/jbc.M113.458687. Epub 2013 Jun 11.
4
Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial.注射用缓释纳曲酮治疗阿片类物质依赖:一项随机、安慰剂对照试验。
Arch Gen Psychiatry. 2006 Feb;63(2):210-8. doi: 10.1001/archpsyc.63.2.210.
5
Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists.对μ-阿片受体激动剂辨别刺激效应的敏感化和耐受性。
Psychopharmacology (Berl). 1994 May;114(4):601-10. doi: 10.1007/BF02244991.
6
Increased sensitivity to rate-altering and discriminative stimulus effects of morphine following continuous exposure to naltrexone.
Psychopharmacology (Berl). 1991;103(1):67-73. doi: 10.1007/BF02244076.